Navigation Links
Job Research Foundation Makes Scientific Advisory Board Appointments: Prof. Alain Fischer, MD as Chief Scientific Officer, Prof. Andrew R. Gennery, MD Named to Board
Date:2/19/2019

Job Research Foundation, which seeks to help find a cure for Job Syndrome by providing the scientific community with additional opportunities to further research into the rare immunodeficiency disorder, has announced the appointment of Dr. Alain Fischer as Chief Scientific Officer of the Foundation’s Scientific Advisory Board and the addition of Dr. Andrew R. Gennery to the Foundation’s Scientific Advisory Board.

Dr. Alain Fischer studied medicine, with a specialization in pediatrics, biochemistry, and pediatric immunology at the Université Paris Jussieu, where he received his medical and doctoral degrees in the same year. After completing a postdoctoral fellowship at the University College London, he started independent research in a unit of the National Health Institute of Medical Research (INSERM) at the Necker Hospital in Paris. Since 1991, he has been the director of an INSERM unit for “normal and pathological development of the immune system.” Dr. Fischer also serves as a professor of pediatric immunology at the Université Paris Descartes and as a professor at the Institut Universitaire de France. Since 1996, he has served as the director of the pediatric immunology department at the Necker Hospital. He has been the founding director of the Imagine Institute on the Necker campus that gathers 500 scientists working on genetic diseases. Since 2014, he is professor at Collège de France, Paris. Dr. Fischer has received numerous awards and honors for his work in medicine and has authored more than 800 scientific papers. He has been an editor of the European Journal of Immunology, International Immunology, the EMBO Journal, Clinical and Experimental Immunology, the Annual Review of Immunology, and Science.

Dr. Andrew R. Gennery currently serves as Honorary Consultant in Paediatric Immunology and Haematopoietic Stem Cell Transplantation at The Newcastle Upon Tyne Hospitals in England. Dr. Gennery spent a year of post-doctoral studies working with Anne Durandy and Alain Fischer in the Necker Hospital in Paris and was involved in the discovery of Cytidine Deaminase one of the first genes to be discovered involved in class switch recombination and somatic hypermutation. Dr. Gennery has adapted new methods of T-cell depletion for patients with primary immunodeficiency and established extracorporeal photopheresis for the treatment of children with acute graft versus host disease. Dr. Gennery has written international guidelines for the treatment of patients with DNA repair disorders and CD40 ligand deficiency and is currently part of the working group writing guidelines for the use of extracorporeal photopheresis for the treatment of acute graft versus host disease. Dr. Gennery is currently Programme Director for the Academic Foundation Programme in the Northern Deanery and the Human Tissue Authority Designated Individual overseeing tissue for therapeutic use within Newcastle.

Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), was discovered in 1966 and is a multisystem immunodeficiency disorder found in males and females worldwide. It can be inherited from either parent or result from a new genetic mutation, a mutation of the STAT3 gene, which is encoded on chromosome 17q21. Approximately 300 cases of Job’s Syndrome have been reported since it was first discovered. Patients often suffer from life-threatening complications from basic infections as the disease makes the immune system extremely sensitive to bacteria. People with the syndrome often have multiple, recurring ailments, such as skin infections that cause lesions and boils, and lung infections that cause pneumonia. Visit http://www.jobresearchfoundation.org for additional information about The Job Research Foundation.

Read the full story at https://www.prweb.com/releases/job_research_foundation_makes_scientific_advisory_board_appointments_prof_alain_fischer_md_as_chief_scientific_officer_prof_andrew_r_gennery_md_named_to_board/prweb16112962.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. METAvivor Announces 2019 Cancer Metastasis Research Grant Competition
2. Mount Sinai Research Program Awarded $12.5 Million NIH Grant to Continue to Study the Role of Hormones in Menopause and Aging Biology
3. Rett Syndrome Research Trust Awards $10 Million to Preeminent Researchers in Pursuit of Curing Devastating Neurological Disorder
4. Award-Winning CSUN Psychology Professor and Film Director Luciana Lagana Shares the Main Achievements of her Research Laboratory Accomplished in the Year 2018.
5. Researchers Discover That Kidney Disease Gene Affects More Populations Than Previously Thought
6. New Lyme Disease Research & Awareness Partnership Aims to Turn Tragedy to Hope
7. Mount Sinai Researchers Discover New Drug Cocktail That Increases Human Beta Cell Proliferation at Rapid Rates
8. New Research Points to Stark Differences in Stress Among Generations Especially in Gen Z
9. Designs for Health Launches New Clinically Researched Natural Vitamin E Tocotrienol Product
10. Over 205,000 Demand An Increase In Type 1 Diabetes Cure Research Funding
11. DNASTAR and Bioz have Partnered to Increase Researcher Confidence Using Structured Insights from Peer-Reviewed Scientific Articles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2019)... BEVERLY HILLS, Calif. (PRWEB) , ... November 20, 2019 , ... The Lifedriven Foundation along ... its Mixing it Up with the Champs event from 8 to 11 p.m. on Friday, ... Vegas. This fundraising event will take place on the eve of the PBC Heavyweight Title ...
(Date:11/20/2019)... ... November 20, 2019 , ... “Analysis of the Biofield ... Assay” by Maria Isabel Aguilar has been named No. 1 International Best Seller ... Research, Holistic, Mind-Body Medicine, Allied Health Professions, and Energy Healing. , The aim ...
(Date:11/19/2019)... ... ... “Protective Role of the Biofield Energy Treated Test Formulation on Vital Organs ... Best Seller on Amazon in the USA, Canada, and United Kingdom in 19 categories ... named a hot new release in multiple categories in the USA, Canada, and United ...
Breaking Medicine Technology:
(Date:11/21/2019)... , ... November 21, 2019 , ... ... chall@charteroak.edu; 860-515-3889 , Middlesex Health Care Awarded the Golden Acorn by the Charter ... , The Foundation for Charter Oak State College, Connecticut’s public online college, recently ...
(Date:11/21/2019)... ... November 21, 2019 , ... PointClickCare, ... post-acute care and senior care industry, has named Richter as its 2019 ... Richter and PointClickCare on targeted training activities related to Medicare Patient-Driven Payment ...
(Date:11/20/2019)... ... November 20, 2019 , ... Fujirebio ... and Drug Administration (FDA) clearance of the company’s Lumipulse® G whole PTH Assay ... a hormone secreted by the parathyroid glands; which are four small glands located ...
(Date:11/20/2019)... , ... November 20, 2019 , ... ... Health Specific Biomarkers Using Cell Line Study” by Ariadne Esmene Afaganis has been ... Kingdom in many categories including Nervous System, Molecular Biology, Energy Healing, Public Health, ...
(Date:11/19/2019)... (PRWEB) , ... November 19, 2019 , ... It was ... marathon with a bike ride along the Charles River in Boston. Days later, Bernie ... to him, yet he struggled to know exactly who all of them were. For ...
Breaking Medicine News(10 mins):